We just received data on a new analyst forecast for $CERS. Mark Massaro from BTIG set a price target of 4.0 for CERS.
To track analyst ratings and price targets for $CERS, check out Quiver Quantitative's $CERS forecast page.
Should you buy $CERS?
Some analysts are better than others. To view the past performance of BTIG, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CERS Insider Trading Activity
$CERS insiders have traded $CERS stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CERS stock by insiders over the last 6 months:
- WILLIAM MARINER GREENMAN (President and CEO) has made 0 purchases and 2 sales selling 525,944 shares for an estimated $898,826.
- RICHARD J BENJAMIN (Chief Medical Officer) has made 0 purchases and 4 sales selling 227,634 shares for an estimated $419,541.
- KEVIN DENNIS GREEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 210,565 shares for an estimated $381,012.
- VIVEK K JAYARAMAN (Chief Operating Officer) has made 0 purchases and 2 sales selling 199,294 shares for an estimated $342,144.
- CHRYSTAL JENSEN (Chief Legal Officer) has made 0 purchases and 2 sales selling 85,845 shares for an estimated $155,359.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$CERS Revenue
$CERS had revenues of $59.9M in Q1 2026. This is an increase of 22.6% from the same period in the prior year.
You can track CERS financials on Quiver Quantitative's CERS stock page.
$CERS Hedge Fund Activity
We have seen 74 institutional investors add shares of $CERS stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 4,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,240,000
- MILLENNIUM MANAGEMENT LLC removed 2,502,368 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $5,154,878
- AMOVA ASSET MANAGEMENT AMERICAS, INC. removed 975,218 shares (-17.2%) from their portfolio in Q4 2025, for an estimated $2,008,949
- BLACKROCK, INC. added 938,737 shares (+4.5%) to their portfolio in Q4 2025, for an estimated $1,933,798
- UBS GROUP AG added 793,244 shares (+227.1%) to their portfolio in Q4 2025, for an estimated $1,634,082
- TWO SIGMA INVESTMENTS, LP added 712,678 shares (+62.3%) to their portfolio in Q4 2025, for an estimated $1,468,116
- ARK INVESTMENT MANAGEMENT LLC removed 649,984 shares (-3.4%) from their portfolio in Q4 2025, for an estimated $1,338,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
